Completing the RWHAP Parts C and D Allocations and Expenditures Reports
Resource updated 05/09/2024
Resource updated 05/09/2024
Resource from the RWHAP Best Practices Compilation updated on 04/01/2024
Resource from the RWHAP Best Practices Compilation updated on 02/20/2024
Resource updated 04/07/2023
Resource (Conference Presentation) updated 09/14/2023
Features and outcomes of a program for exclusively breastfed infants followed in a multidisciplinary program for women with HIV.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource updated 04/16/2024
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource updated 04/03/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023